Pages that link to "Q2034327"

The following pages link to Pauls Stradins Clinical University Hospital (Q2034327):

Displayed 50 items.

• Mārtiņš Rītiņš (Q282036) ‎ (← links)
• Hugo Legzdiņš (Q3142412) ‎ (← links)
• Andrejs Ērglis (Q20796860) ‎ (← links)
• Uga Dumpis (Q20796869) ‎ (← links)
• Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis (Q61862245) ‎ (← links)
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis (Q61862270) ‎ (← links)
• Effect of a Plant-based Hydrolyasre Daily Consumption on the HbA1c of Pre-diabetic Subjects (Q61865522) ‎ (← links)
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) (Q61955394) ‎ (← links)
• Atrial Fibrillation Progression Trial (Q63316916) ‎ (← links)
• BIOFLOW-III All-comers Orsiro Safety and Performance Registry (Q63319212) ‎ (← links)
• Study of the Orsiro Drug Eluting Stent System (Q63336609) ‎ (← links)
• To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (Q63394671) ‎ (← links)
• The PROTEMBO SF Trial (Q63534406) ‎ (← links)
• Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 (Q63590453) ‎ (← links)
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2) (Q63590702) ‎ (← links)
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease (Q63811743) ‎ (← links)
• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease (Q63811752) ‎ (← links)
• Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease (Q63811782) ‎ (← links)
• Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis (Q63818569) ‎ (← links)
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) (Q63838015) ‎ (← links)
• Phase IV-Cervical Dystonia-INTEREST IN CD2 (Q63839561) ‎ (← links)
• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis (Q64122040) ‎ (← links)
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection (Q64139976) ‎ (← links)
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (Q64149781) ‎ (← links)
• Inhalational Anesthesia and Precipitation of Dementia: is There a Link? (Q64150466) ‎ (← links)
• BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction (Q64151733) ‎ (← links)
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease (Q64216670) ‎ (← links)
• Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Under (Q64219979) ‎ (← links)
• Effects of Oral Sildenafil on Mortality in Adults With PAH (Q64335588) ‎ (← links)
• Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections (Q64352686) ‎ (← links)
• A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes (Q64354039) ‎ (← links)
• Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) (Q64393362) ‎ (← links)
• Phase 3 Study of RPC1063 in Relapsing MS (Q64598539) ‎ (← links)
• Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation (Q64598859) ‎ (← links)
• Safety and Performance Study of the Moderato System (Q64599866) ‎ (← links)
• Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice (Q64656619) ‎ (← links)
• Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly (Q64662209) ‎ (← links)
• Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. (Q64791195) ‎ (← links)
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Q64802411) ‎ (← links)
• A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis (Q65316797) ‎ (← links)
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) (Q65338587) ‎ (← links)
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) (Q65338593) ‎ (← links)
• The European Bifurcation Club Left Main Study (Q65344374) ‎ (← links)
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] (Q65348384) ‎ (← links)
• Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer (Q65348900) ‎ (← links)
• CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI (Q65353017) ‎ (← links)
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread (Q65353631) ‎ (← links)
• Bifurcation Lesion Analysis and STenting / BLAST (Q65354636) ‎ (← links)
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors (Q65376346) ‎ (← links)
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus (Q65387141) ‎ (← links)